• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Aldeyra Therapeutics

Biotech

Aldeyra dry eye med notches another clinical win

Aldeyra's dry med was successful in a crossover trial, another clinical win as the company nears a formal approval submission.
Max Bayer Jul 12, 2022 10:45am

After late-study switch, Aldeyra hails win in dry eye phase 3

Jun 8, 2022 9:30am

Aldeyra dry eye drug helps with redness, misses secondary goals

Nov 2, 2021 11:00am

Aldeyra halts trials, focuses on ocular assets to stretch runway

Mar 12, 2020 10:20am

Aldeyra’s eye allergy drug sails through first phase 3 trial

Mar 26, 2019 9:54am

Aldeyra boosts eye disease pipeline with $10M Helio Vision buy

Jan 29, 2019 11:19am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy